SCHEMBL6002444

SCHEMBL6002444

CCCCCOS(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.47
CYP3A4 P08684 2/20 0.47
TP53 P04637 1/20 0.47
MAPK1 P28482 1/20 0.47
LMNA P02545 3/20 0.46
ALDH1A1 P00352 2/20 0.46
LTA4H P09960 2/20 0.44
EPHX2 P34913 1/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP24A1 Q07973 1/20 0.40
CNR2 P34972 1/20 0.40
PTPN1 P18031 1/20 0.40
MEN1 O00255 1/20 0.38
NR1I2 O75469 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27521423 0.98 TSHR (0.49) TSHRCYP3A4TP53MAPK1LMNA
SCHEMBL8915435 0.98 TSHR (0.49) TSHRCYP3A4TP53MAPK1LMNA
SCHEMBL20526214 0.98 TSHR (0.49) TSHRCYP3A4TP53MAPK1LMNA
SCHEMBL29575676 0.96 TSHR (0.47) TSHRCYP3A4TP53MAPK1LMNA
SCHEMBL30528958 0.96 TSHR (0.47) TSHRCYP3A4TP53MAPK1LMNA
SCHEMBL6002555 0.94 TSHR (0.46) TSHRCYP3A4TP53MAPK1LMNA
SCHEMBL11286528 0.86 LMNA (0.46) TSHRCYP3A4TP53MAPK1LMNA
SCHEMBL28316278 0.85 LMNA (0.44) TSHRCYP3A4TP53MAPK1LMNA
SCHEMBL6745076 0.84 RECQL (0.46) TSHRCYP3A4TP53MAPK1LMNA
Tetrabuthylammonium SCHEMBL5702394 0.79 SLC22A1 (0.41) TSHRCYP3A4TP53MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed